TY - JOUR
T1 - Home- versus office-based buprenorphine inductions for opioid-dependent patients
AU - Sohler, Nancy L.
AU - Li, Xuan
AU - Kunins, Hillary V.
AU - Sacajiu, Galit
AU - Giovanniello, Angela
AU - Whitley, Susan
AU - Cunningham, Chinazo O.
N1 - Funding Information:
This study was supported by the Health Resources and Services Administration, HIV/AIDS Bureau, Special Projects of National Significance (Grant 6H97HA00247), the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519), NIH R25 DA023021, and the Robert Wood Johnson Foundation's Harold Amos Medical Faculty Development Program. An earlier version of this analysis was presented at the North America Primary Care Research Group Conference in Rio Grande Puerto Rico, November 2009, and the Society of General Internal Medicine Annual Meeting in Miami, FL, May 2009. We thank Ms. Mia Brisbane and Ms. Johanna Rivera for their help in entering and cleaning these data.
PY - 2010/3
Y1 - 2010/3
N2 - Recent legislation permits the treatment of opioid-dependent patients with buprenorphine in the primary care setting, opening doors for the development of new treatment models for opioid dependence. We modified national buprenorphine treatment guidelines to emphasize patient self-management by giving patients the opportunity to choose to have buprenorphine inductions at home or the physician's office. We examined whether patients who had home-based inductions achieved greater 30-day retention than patients who had traditional office-based inductions in a study of 115 opioid-dependent patients treated in an inner-city health center. Retention was similar in both groups: 50 (78.1%) in office-based group versus 40 (78.4%) in home-based group, p = .97. Several patient characteristics were associated with choosing office- versus home-based inductions, which likely influenced these results. We conclude that opioid dependence can be successfully managed in the primary care setting. Approaches that encourage patient involvement in treatment for opioid dependence can be beneficial.
AB - Recent legislation permits the treatment of opioid-dependent patients with buprenorphine in the primary care setting, opening doors for the development of new treatment models for opioid dependence. We modified national buprenorphine treatment guidelines to emphasize patient self-management by giving patients the opportunity to choose to have buprenorphine inductions at home or the physician's office. We examined whether patients who had home-based inductions achieved greater 30-day retention than patients who had traditional office-based inductions in a study of 115 opioid-dependent patients treated in an inner-city health center. Retention was similar in both groups: 50 (78.1%) in office-based group versus 40 (78.4%) in home-based group, p = .97. Several patient characteristics were associated with choosing office- versus home-based inductions, which likely influenced these results. We conclude that opioid dependence can be successfully managed in the primary care setting. Approaches that encourage patient involvement in treatment for opioid dependence can be beneficial.
KW - Buprenorphine induction
KW - Buprenorphine treatment
KW - Community health center
KW - Opioid dependence
KW - Primary care
UR - http://www.scopus.com/inward/record.url?scp=74249083192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74249083192&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2009.08.001
DO - 10.1016/j.jsat.2009.08.001
M3 - Article
C2 - 19801178
AN - SCOPUS:74249083192
SN - 0740-5472
VL - 38
SP - 153
EP - 159
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 2
ER -